Pharmacological study of 6,11-dihydro-11-oxodibenz[b,e]oxepin-3-acetic acid (oxepinac): a new antiinflammatory drug.
D000085:Acetates / Q000494:pharmacology*; D000700:Analgesics; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002199:Capillary Permeability / Q000187:drug effects; D002417:Cattle; D055598:Chemical Phenomena; D002621:Chemistry; D003990:Dibenzoxepins / Q000494:pharmacology*; D004064:Digestive System / Q000187:drug effects; D005260:Female; D006168:Guinea Pigs; D006461:Hemolysis / Q000187:drug effects; D066298:In Vitro Techniques; D008099:Liver / Q000648:ultrastructure; D008247:Lysosomes / Q000187:drug effects; D008297:Male; D051379:Mice; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000096:biosynthesis; D011506:Proteins; D011817:Rabbits; D051381:Rats
D000085:Acetates; D000700:Analgesics; D000893:Anti-Inflammatory Agents; D003990:Dibenzoxepins; D011453:Prostaglandins; D011506:Proteins